@article{8dfe432fef3c4ca48c217fbf600870a6,
title = "Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes",
abstract = "[This corrects the article DOI: 10.3389/fmed.2022.1092688.].",
keywords = "ixekizumab, moderate-to-severe psoriasis, obesity, prediabetes, type 2 diabetes",
author = "Alexander Egeberg and Merola, {Joseph F} and Knut Sch{\"a}kel and Luis Puig and Mahar, {Patrick D} and Wang, {Isabella Yali} and Imre Pavo and Christopher Schuster and Griffiths, {Christopher E M}",
note = "Copyright {\textcopyright} 2023 Egeberg, Merola, Sch{\"a}kel, Puig, Mahar, Wang, Pavo, Schuster and Griffiths.",
year = "2023",
doi = "10.3389/fmed.2023.1171132",
language = "English",
volume = "10",
pages = "1171132",
journal = "Frontiers in Medicine",
issn = "2296-858X",
publisher = "Frontiers Media S.A.",
}